2023 – Neurinnov announces its participation in the DREIMS European project under the HORIZON EIC-2023-TRANSITION programme. The project will last for 36 months and aims to design and develop a multi-contact neural stimulator based on the company’s selective neural stimulation technology to treat spinal cord injuries. The project will combine biomaterials, pharmaceuticals, and electrical stimulation to create an innovative therapeutic solution capable of promoting spinal cord gap closure, axonal regrowth, and glial cell migration across large lesions in rodent and porcine models of spinal cord injury.
For more information, visit the DREIMS website at: http://www.dreims-project.eu